Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Finasteride increases risk of sleep apnea and insomnia.

The man's symptoms improved and the tumor shrank after treatment with cabergoline.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

HVDRR is caused by VDR gene mutations, leading to vitamin D resistance, treatable with high calcium doses, but alopecia remains permanent.

Ruxolitinib treatment may cause eyelash growth.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The woman had a genetic condition causing high cortisol and androgen levels, treatable with dexamethasone.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Minoxidil and finasteride for hair loss may cause different types of heart rhythm issues.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

A new gene mutation causes insulin resistance in a girl and her mother.

The assay effectively detects hormonal activity of certain chemicals.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Regional prescribing of ritlecitinib mostly follows national guidance, but psychological assessments and consistent scoring need improvement.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Finasteride may increase the risk of depression and suicidal thoughts.

High doses of ethynylestradiol in rats caused growth issues, organ changes, and some tumors, but didn't increase overall tumor rates.

Finasteride helps induce ovulation in nonresponder PCOS women.

Finasteride, a medication, is being re-evaluated for its effects and uses.